OBZEO

Live / Allowed — Published for opposition (as of 03 Mar 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Feb 2025 filing date already counts against anyone who files later.

Record

Serial number
99048593
Mark type
Stylized text
Filed
20 Feb 2025
Published for opposition
03 Mar 2026
Attorney of record
Karen Won

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for medical purposes, namely, immunology-based therapies for autoimmune diseases; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology for medical purposes; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake for medical purposes; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system

Owner

Prosecution history

  • 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 03 Mar 2026 — PUBLISHED FOR OPPOSITION
  • 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 04 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 03 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 03 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 03 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 03 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
  • 03 Feb 2026 — PETITION TO REVIVE-GRANTED
  • 03 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
  • 23 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 23 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 30 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 30 Jul 2025 — NON-FINAL ACTION E-MAILED
  • 30 Jul 2025 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy